Search
for
Sort by
Research 31–60 of 71
- Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study
- Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study
- Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study
- Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study"
- Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study"
- Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study"
- Broad laboratory testing does not show utility for telogen effluvium: a retrospective analysis of 22-million laboratory results using TriNetX
- Increased risk of telogen effluvium with tirzepatide compared to other weight-loss medications: a retrospective cohort TriNetX database study
- When hair dig into the brain, JAKi , may help!
- The Risk of Benign Prostatic Hyperplasia and Prostate Cancer With Long-Term, Low Dose Finasteride Use in Adult Men with Nonscarring Alopecia: A Propensity-Matched Observational Study
- 53028 Semaglutide and Hair Loss: A Real-World Analysis
- LB892 Assessing the risk of alopecia areata development in patients with seasonal and food allergies: a matched population-level analysis
- Low serum testosterone is associated with an increased risk of first-time renal calculi in men without testosterone replacement therapy
- Simultaneous Versus Delayed Initiation of Spironolactone and Low‐Dose Oral Minoxidil: Adverse Event Rates in a Retrospective Cohort Study
- 0282 Effect of systemic immunomodulators on incidence of alopecia areata: A retrospective cohort study
- Burden of Eosinophilic Esophagitis and Gastroesophageal Reflux Disease in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Comprehensive US Healthcare Analysis
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
- Association of Janus kinase inhibitors with reduced depression in alopecia areata
- Menopause and Common Dermatoses: A Systematic Review
- Semaglutide and the Skin: An Overview of Current Evidence
- 0413 IL-17 Inhibitors vs. methotrexate in preventing new-onset psoriatic arthritis in psoriasis patients: a retrospective population-level analysis
- Celiac disease associated with alopecia areata: A multicenter case-control study
- IP28-24 RISK OF ERECTILE DYSFUNCTION AMONG REPRODUCTIVE-AGED MEN FOLLOWING LOW-DOSE FINASTERIDE USE FOR ANDROGENETIC ALOPECIA: A PROPENSITY-MATCHED COHORT STUDY
- Androgenetic alopecia is not associated with increased incidence of cardiovascular disease risk factors: A retrospective cohort study
- Abstracts from the 2025 WDS Forum
- 61131 Impact of Low-Dose Oral Minoxidil on Blood Pressure in Androgenetic Alopecia Patients Concomitantly Taking Antihypertensive Medications: A Multi-Center Cohort Study
- 0415 Spironolactone treatment for dermatologic conditions and blood pressure changes in hypertensive patients on concomitant antihypertensive therapy
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- 266 Exploring the bidirectional impact of gastrointestinal and rosacea treatments on comorbid patients: A multi-center health records analysis